Stereotactic Ablative Body Radiotherapy (SABR) for Oligometastases

Clinical trial NCT02933242 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT02933242
Sponsor: British Columbia Cancer Agency
Status: ACTIVE_NOT_RECRUITING
Phase: Not Applicable
Study type: INTERVENTIONAL

Metastatic Tumors

Start date: 2016-11-01
Primary completion: 2025-12-01
Enrollment: 399

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.